Literature DB >> 7886478

Case report 874: Left supraorbital osteoblastoma.

R D Snow1, M D Christianson, E A Dowling, B G Brogdon.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7886478     DOI： 10.1007/bf02580392

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  7 in total

1.  Psammomatoid ossifying fibroma of the orbit.

Authors:  D R Jordan; J Farmer; V DaSilva
Journal:  Can J Ophthalmol       Date:  1992-06       Impact factor: 1.882

2.  Benign osteoblastoma of the orbit.

Authors:  C R Leone; A W Lawton; R T Leone
Journal:  Ophthalmology       Date:  1988-11       Impact factor: 12.079

Review 3.  Diseases of the intracranial meninges: MR imaging features.

Authors:  G Sze
Journal:  AJR Am J Roentgenol       Date:  1993-04       Impact factor: 3.959

4.  The spectrum of osteoblastoma.

Authors:  R A McLeod; D C Dahlin; J W Beabout
Journal:  AJR Am J Roentgenol       Date:  1976-02       Impact factor: 3.959

5.  Benign osteoblastoma of the orbit.

Authors:  C Y Lowder; A J Berlin; W A Cox; J F Hahn
Journal:  Ophthalmology       Date:  1986-10       Impact factor: 12.079

6.  Osteoblastoma: clinical and radiologic findings in 98 new cases.

Authors:  H M Kroon; J Schurmans
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

7.  Benign osteoblastoma. Report of a case and review of the literature.

Authors:  D J Clutter; D A Leopold; L V Gould
Journal:  Arch Otolaryngol       Date:  1984-05
  7 in total
  2 in total

Review 1.  Osteoblastoma of the calvaria: report of two cases diagnosed with MRI and clinical review.

Authors:  L Cervoni; G Innocenzi; M Raguso; M Salvati; R Caruso
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

Review 2.  Malignant transformation of an osteoblastoma of the mandible: case report and review of the literature.

Authors:  Aldona W Woźniak; Marian Tomasz Nowaczyk; Krzysztof Osmola; Wojciech Golusinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-10       Impact factor: 2.503
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.